C21.1

Clinical Causes: Human papillomavirus (HPV) infection, especially high-risk types Smoking and tobacco use Chronic anal fistulas or other longstanding anal conditions Immunosuppression, including HIV infection or organ transplantation History of other anal or colorectal cancers Certain genetic predispositions

Key Symptoms: Rectal bleeding or blood on stool Discomfort, pain, or pressure in the anal area Itching or irritation around the anus A lump or mass near the anus Change in bowel habits, such as diarrhea or constipation Sensation of incomplete bowel evacuation

Diagnosis Path: The diagnosis of malignant neoplasm of the anal canal involves multiple steps to confirm the presence and extent of the disease. These elements typically include: - **Medical history and physical examination** focusing on the anal and rectal area - **Digital rectal exam** to identify any palpable abnormalities - **Anoscopy or proctoscopy**, allowing direct visualization of the anal canal - **Biopsy** of suspicious lesions to determine malignancy - **Imaging studies** such as MRI, CT scan, or endoscopic ultrasound to evaluate the local spread and regional lymph node involvement - **Blood tests** for general health assessment and tumor markers, if applicable

Treatment Protocols: Treatment strategies for malignant neoplasm of the anal canal generally involve a combination of modalities tailored to the tumor stage and patient health. Common approaches include: - **Chemoradiotherapy**, often the primary treatment for preserving the anal sphincter, combining chemotherapy and radiation therapy - **Surgical intervention**, such as abdominoperineal resection, performed if the tumor is extensive or unresponsive to other treatments - **Targeted therapy** or immunotherapy, under investigation or in specific cases - **Supportive care** to manage side effects and improve quality of life The multidisciplinary approach ensures comprehensive management aimed at controlling the tumor and maintaining function.